Pravastatin Sodium 40 mg Tablets Food Challenge Study
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2020-01-09
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00834847
- Locations
- 🇨🇦
Pharma Medica Research Inc., Toronto, Ontario, Canada
Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00834639
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 38
- Registration Number
- NCT00833521
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States
Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00833937
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Terbinafine HCl 250 mg Tablet Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00833586
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States
Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2023-05-30
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 22
- Registration Number
- NCT00833664
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States
Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00829452
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT00830024
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 16
- Registration Number
- NCT00829309
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 30
- Registration Number
- NCT00829790
- Locations
- 🇺🇸
CEDRA Clinical Research, San Antonio, Texas, United States